Be wary of the third killer of adolescent health concerned with scoliosis medical treatment

According to the early circulation data of the Spine Disease Prevention and Control Committee of the Chinese Preventive Medicine Association, combined with authoritative journals and domestic expert consensus, it is expected that the number of scoliosis in primary and secondary school students in China has exceeded 5 million, and it is still increasing at a rate of about 300,000 per year. Scoliosis has become the third major disease that endangers the health of children and adolescents in China after obesity and myopia.

Scoliosis is a deformity caused by the spine deviating from the normal midline. Experts say scoliosis is a three-dimensional structural deformity that is more likely to occur during puberty. And epidemiological surveys have shown that women at the peak of growth and development are more likely to suffer from this disease, with an incidence of up to 1.5 times that of men. Scoliosis not only affects the patient's physical appearance, but also causes muscle tension, resulting in back pain. When scoliosis is severe to a certain extent, it can also cause nerve damage, compress the lungs, and even affect breathing.

With the increase in the importance of the country and the public, the growth of related medical care can be expected.

1) Sanyou Medical (688085)\ The main products are orthopedic spine implant consumables and trauma implant consumables. The company has established a high brand awareness in the field of spinal implant segmentation, with a relatively leading market position;

2) Weigao Orthopaedics (688161) \ has been focusing on the research and development of orthopedic medical device products, and occupies a leading position in this field in China. The company is the only domestic manufacturer among the top five companies, with a market share of 4.61% in 2019, which is a small gap in market share with some foreign giants. With the deepening trend of import substitution, the company's industry market position will be further consolidated;

3) KellyTek (300326) \ mainly engaged in the research and development, production and sales of orthopedic implants, the main products are vertebroplasty minimally invasive interventional surgical system, spine and trauma orthopedic implants, etc. Its main revenue in 2020 was 1.050 billion yuan, of which the income of minimally invasive products of vertebral body forming accounted for 43.07% of the main business income, and the income of orthopedic spine or trauma products accounted for 16.90% of the main business income.

This article originated from the financial world